FY2025 EPS Estimates for Transcat Reduced by Northland Capmk

Transcat, Inc. (NASDAQ:TRNSFree Report) – Northland Capmk lowered their FY2025 earnings per share estimates for Transcat in a research note issued on Wednesday, January 29th. Northland Capmk analyst E. Jackson now expects that the scientific and technical instruments company will earn $2.24 per share for the year, down from their previous estimate of $2.34. The consensus estimate for Transcat’s current full-year earnings is $2.44 per share. Northland Capmk also issued estimates for Transcat’s Q4 2025 earnings at $0.59 EPS and FY2026 earnings at $2.28 EPS.

Several other equities analysts have also commented on TRNS. Craig Hallum upped their price objective on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. StockNews.com upgraded Transcat from a “sell” rating to a “hold” rating in a research note on Tuesday. HC Wainwright dropped their price objective on Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a research note on Wednesday. Northland Securities reissued a “market perform” rating and set a $85.00 target price (down previously from $110.00) on shares of Transcat in a research note on Wednesday. Finally, Oppenheimer downgraded Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, Transcat has a consensus rating of “Hold” and an average price target of $111.50.

Read Our Latest Stock Analysis on TRNS

Transcat Price Performance

Shares of TRNS stock opened at $76.71 on Thursday. Transcat has a 1-year low of $73.37 and a 1-year high of $147.12. The firm has a market cap of $705.73 million, a PE ratio of 38.74 and a beta of 0.71. The company has a 50-day moving average of $103.79 and a two-hundred day moving average of $114.55.

Transcat (NASDAQ:TRNSGet Free Report) last released its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.36% and a net margin of 6.63%. During the same quarter in the previous year, the firm posted $0.56 earnings per share.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Conestoga Capital Advisors LLC raised its position in Transcat by 17.9% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after purchasing an additional 137,830 shares in the last quarter. Royce & Associates LP raised its holdings in Transcat by 8.2% in the third quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company’s stock valued at $61,798,000 after acquiring an additional 38,774 shares in the last quarter. Champlain Investment Partners LLC lifted its stake in Transcat by 22.1% in the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after acquiring an additional 74,169 shares during the last quarter. Geode Capital Management LLC grew its holdings in Transcat by 5.4% during the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock worth $26,269,000 after acquiring an additional 11,106 shares in the last quarter. Finally, State Street Corp increased its position in shares of Transcat by 8.1% in the 3rd quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock valued at $25,027,000 after purchasing an additional 15,514 shares during the last quarter. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

About Transcat

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Read More

Earnings History and Estimates for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.